XP-828l

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
In a placebo-controlled clinical trial, the dietary supplement XP-828L (commercialized as Dermylex) demonstrated potential to… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2007
2007
Natural health products (NHPs) or complementary and alternative medicine (CAM) are commonly used to prevent disorders or support… (More)
Is this relevant?
2007
2007
Advitech is the developer of XP-828L. Abstract Background: XP-828L, a protein extract obtained from sweet whey, has demonstrated… (More)
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 5
Is this relevant?
2007
2007
Natural health products (NHPs) or complementary and alternative medicine (CAM) are commonly used to prevent disorders or support… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2007
2007
BACKGROUND XP-828L, a protein extract obtained from sweet whey, has demonstrated potential benefit for the treatment of mild to… (More)
Is this relevant?
2006
2006
BACKGROUND XP-828L, a protein extract obtained from sweet whey, has demonstrated potential benefit for the treatment of mild to… (More)
  • figure 1
  • table 1
  • table 2
  • table 5
  • figure 2
Is this relevant?
2005
2005
BackgroundXP-828L is a nutraceutical compound obtained by the extraction of a growth factors-enriched protein fraction from… (More)
Is this relevant?